Zhou Sheng-Yu, Guo Zhen-Ni, Zhang Dian-Hui, Qu Yang, Jin Hang
Department of Neurology, Stroke Center, The First Hospital of Jilin University, Changchun, China.
Clinical Trial and Research Center for Stroke, Department of Neurology, The First Hospital of Jilin University, Changchun, China.
Front Mol Neurosci. 2022 Apr 13;15:866700. doi: 10.3389/fnmol.2022.866700. eCollection 2022.
Ischemic stroke (IS) is a cerebrovascular disease causing high rates of disability and fatality. In recent years, the concept of the neurovascular unit (NVU) has been accepted by an increasing number of researchers and is expected to become a new paradigm for exploring the pathogenesis and treatment of IS. NVUs are composed of neurons, endothelial cells, pericytes, astrocytes, microglia, and the extracellular matrix. As an important part of the NVU, pericytes provide support for other cellular components and perform a variety of functions, including participating in the maintenance of the normal physiological function of the blood-brain barrier, regulating blood flow, and playing a role in inflammation, angiogenesis, and neurogenesis. Therefore, treatment strategies targeting pericyte functions, regulating pericyte epigenetics, and transplanting pericytes warrant exploration. In this review, we describe the reactions of pericytes after IS, summarize the potential therapeutic targets and strategies targeting pericytes for IS, and provide new treatment ideas for ischemic stroke.
缺血性中风(IS)是一种导致高致残率和高死亡率的脑血管疾病。近年来,神经血管单元(NVU)的概念已被越来越多的研究人员所接受,并有望成为探索缺血性中风发病机制和治疗方法的新范式。神经血管单元由神经元、内皮细胞、周细胞、星形胶质细胞、小胶质细胞和细胞外基质组成。作为神经血管单元的重要组成部分,周细胞为其他细胞成分提供支持,并执行多种功能,包括参与维持血脑屏障的正常生理功能、调节血流以及在炎症、血管生成和神经发生中发挥作用。因此,针对周细胞功能、调节周细胞表观遗传学以及移植周细胞的治疗策略值得探索。在这篇综述中,我们描述了缺血性中风后周细胞的反应,总结了针对缺血性中风周细胞的潜在治疗靶点和策略,并为缺血性中风提供了新的治疗思路。